Navigation Links
Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines

CALGARY, April 17, 2007 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") announces that a poster by Dr. Maureen E. Lane et al. of , New York, entitled "In Vivo Synergy between Oncolytic Reovirus and Gemcitabine in Ras-Mutated Human HCT116 Xenografts" is scheduled to be presented today at the American Association for Cancer Research (AACR) Annual Meeting in Los Angeles, CA. The meeting runs from April 14-18, 2007.

The researchers found that treatment of human colon cancer cell lines with the combination of REOLYSIN(R) and gemcitabine resulted in both in vitro and in vivo synergy. There was no toxicity associated with the combined treatment. Tumours treated with the combination were significantly smaller (by area and weight) than tumours in control groups or tumours treated with either agent alone. The researchers concluded that the synergistic combination of REOLYSIN(R) and gemcitabine is a promising therapeutic regimen for study in clinical trials.

"It is rare to see the virtual elimination of tumours as well as the long-lasting therapeutic effect that we have observed from this study," said Dr. Brad Thompson, President and CEO of Oncolytics. "We are very encouraged by these results and look forward to testing this particular treatment combination in our upcoming human systemic administration trial in the U.K."

The poster will be available on the Oncolytics website today at www.oncolyticsbiotech.com.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about
'"/>




Page: 1 2 3

Related medicine technology :

1. Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S. Phase I REOLYSIN Trial
2. Oncolytics Biotech Inc.s Research Collaborators to Present REOLYSIN Clinical Trial Data at ASCO Conference
3. Oncolytics Biotech Inc. Collaborators to Present Reovirus/Gemcitabine Combination Research at AACR Annual Meeting
4. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
5. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
8. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
9. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
10. New Positive Pre-clinical Data for Active Biotechs RA Project I-3D
11. Prana Biotechnology Presents New Key Findings on PBT2

Post Your Comments:
(Date:11/27/2009)...ITY, Nov. 27 Booth - 364...E: VAR ), a premier supplier of X-ray tubes and ...ts full range of detectors at the RSNA Annual Meet..., 2009. Varian will also be exhibiting X-ray tube...cialized cancer treatment technologies. ,, Var...
(Date:11/25/2009)... Calif., Nov. 25 Praxis Electronic...the American Academy of Family Physicians, (AAFP) ...isfaction Survey for improving medical quality, he...ical for new ARRA Stimulus legislation. Praxis als... a positive effect in determining their salary. Fi...
(Date:11/25/2009)...J., Nov. 25 Pharmasset, ...ical company committed to discovering, developing ...ections, reported financial results for the fiscal...009 Pharmasset held $58.4 million in cash, cash eq...line Update and 2009 Highlights ,, RG7128 ,...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10InVitria Reports Successful Cell Culture Performance of Zap CHO a Defined and Cost Effective CHO Cell Culture Media Supplement 60242 1InVitria Reports Successful Cell Culture Performance of Zap CHO a Defined and Cost Effective CHO Cell Culture Media Supplement 60242 2Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 1Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 2Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 3Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 4Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 5Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 6bioMerieux Adds Methicillin resistant Staphylococcus aureus 28MRSA 29 Screening Tool to its Arsenal 5786 1bioMerieux Adds Methicillin resistant Staphylococcus aureus 28MRSA 29 Screening Tool to its Arsenal 5786 2bioMerieux Adds Methicillin resistant Staphylococcus aureus 28MRSA 29 Screening Tool to its Arsenal 5786 3bioMerieux Adds Methicillin resistant Staphylococcus aureus 28MRSA 29 Screening Tool to its Arsenal 5786 4
(Date:11/26/2009)...ge that,s too big or too heavy can lead to strains...ay News) -- There may be nothing wrong with stuffi... want to do the same thing with your suitcase as y...eople were treated in 2008 in U.S. hospital emerge...ical facilities for luggage-related injuries, such...
(Date:11/26/2009)... No more letters from the Nort...sonalized text messages from Santa , ... to increase operational efficiencies at the North...help keep children all over the globe informed of ...s in Santa’s research department have identi...
(Date:11/26/2009)... Research Triangle Dental (RTD... North Carolina, today announced the expansion of ...UMINEER Dentist, Dr. Doug Macmillan. , ...iangle Dental is pleased to announce that Dr. Doug...cently completed an additional advanced training s...
(Date:11/26/2009)... Ennis & Ennis, P.A. is of...for users of Yaz and Yasmin birth control pills wh...onary Embolism, Stroke, Heart Attack or other rela...d. Women can call toll free at 1-800-856-6405 or g...law.com and fill out an online case evaluation fo...
(Date:11/25/2009)... , KANSAS CITY, Mo., Nov. 25 ... become the nation,s largest medical clinic on Dec...ies of massive free clinics for uninsured people. ... be the biggest one yet, because it will extend ov...kdays instead of over a weekend," Sheri Wood, exec...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2
...f thousands of lives saved each year through immun...(HealthDay News) -- The incidence of vaccine-preve...nited States, a new federal report shows. , The st...even previously common childhood illnesses, such a...
...aughter of Mary Kay founder originates idea for a ...ly violence shelters nationwide, WASHINGTON, Nov.... (NNEDV) Fund announced today it is introducing an...opies of this first-of-its kind tool, developed by...
...al Heartburn Alliance Sponsors First Ever Heartbur...ember 2007, CHICAGO, Nov. 13 Heartburn remains a...s each month(1), and this November, the,National H...ts show that 66% of people experience heartburn,sy...
...breaking Meeting Brings Together Cancer Funding Or...cientists from Academic Institutions ...Nov. 13 Leadership and senior staff of,twenty- se...institutions and researchers from the pharmaceutic...
...ew P. Goldberg of the University of Maryland at Ba...ety of America (GSA) to receive its 2007 Joseph T....ectureship in geriatrics and is awarded to a promi...tation will take place at GSA,s 60th Annual Scient...
...UMBIA, Mo. Britney Spears and ex-husband Kevin Fe...ver the custody of their two children. A Universi...ivorce and stepfamily issues said this story shoul...d Larry Ganong, professor and co-chair of the Depa...
Other Medicine News:Health News:Vaccine-Preventable Deaths Reach New Low in U.S. 2Health News:Vaccine-Preventable Deaths Reach New Low in U.S. 3Health News:National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Today's High-Tech World 2Health News:Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 2Health News:Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 3Health News:First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 2Health News:First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 3Health News:First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 4Health News:Britney and K-Fed doing it all wrong, MU family researcher says 2
Fort Moderate Support
Needle Holder (with lock)
Needle Holder (with out lock)
Chang Phaco Chop
Medicine Products: